CELLECTIS S A's ticker is CLLS and the CUSIP is 15117K103. A total of 76 filers reported holding CELLECTIS S A in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $99,811 | -77.8% | 50,522 | -76.1% | 0.00% | – |
| Q4 2022 | $449,640 | -45.1% | 211,467 | -38.5% | 0.00% | – |
| Q3 2022 | $819,000 | -39.9% | 343,894 | -29.9% | 0.00% | -100.0% |
| Q2 2022 | $1,363,000 | -51.1% | 490,230 | -18.7% | 0.00% | 0.0% |
| Q1 2022 | $2,789,000 | +45.5% | 603,253 | +166.5% | 0.00% | 0.0% |
| Q4 2021 | $1,917,000 | -13.3% | 226,391 | +32.9% | 0.00% | 0.0% |
| Q3 2021 | $2,212,000 | -55.1% | 170,286 | +3.0% | 0.00% | -50.0% |
| Q4 2020 | $4,927,000 | +1610.8% | 165,273 | +964.6% | 0.00% | – |
| Q3 2020 | $288,000 | +23.6% | 15,525 | -31.5% | 0.00% | – |
| Q3 2019 | $233,000 | -81.5% | 22,672 | -48.3% | 0.00% | -100.0% |
| Q2 2018 | $1,259,000 | -18.2% | 43,820 | -9.5% | 0.00% | -25.0% |
| Q1 2018 | $1,539,000 | +59.0% | 48,422 | +33.7% | 0.00% | -33.3% |
| Q3 2015 | $968,000 | – | 36,219 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Long Focus Capital Management, LLC | 4,487,293 | $7,089,923 | 0.25% |
| OPPENHEIMER & CO INC | 121,420 | $191,844 | 0.00% |
| CREDIT SUISSE AG/ | 1,438,255 | $2,272,443 | 0.00% |
| Baillie Gifford | 1,164,009 | $1,839,135 | 0.00% |
| PRINCIPAL FINANCIAL GROUP INC | 656,600 | $1,037,428 | 0.00% |
| Capital International Investors | 1,848,804 | $2,921,110 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 1,095,966 | $1,731,626 | 0.00% |
| EverSource Wealth Advisors, LLC | 13 | $21 | 0.00% |
| Qube Research & Technologies Ltd | 40 | $63 | 0.00% |
| Tower Research Capital LLC (TRC) | 111 | $175 | 0.00% |